IBV genotype QX causes suficient disease in Europe for several commercial companies to have started developing live attenuated vaccines. Here, one of those vaccines (L1148) was fully consensus sequenced alongside its progenitor ield strain (1148-A) to determine vaccines markers, thereby enabling detection on farms. Twenty eight single nucleotide substitutions were associated with the 1148-A attenuation, of which any combination can identify vaccine L1148 in the ield. Sixteen substitutions resulted in amino acid coding changes of which half were in spike. One change in the 1b gene altered the normally highly conserved inal 5 nucleotides of the transcription regulatory sequence of the S gene, common to all IBV QX genes. No mutations can currently be associated with the attenuation process. Field vaccination strategies would greatly beneit by such comparative sequence data being mandatorily submitted to regulators prior to vaccine release following a successful registration process

Listorti V., L.A. (2017). IDENTIFICAZIONE DI MARKER MOLECOLARI PER LA DIFFERENZIAZIONE DI UN VACCINO IBV GENOTIPO QX. Parma : La Ducale Srl.

IDENTIFICAZIONE DI MARKER MOLECOLARI PER LA DIFFERENZIAZIONE DI UN VACCINO IBV GENOTIPO QX

Listorti V.
Writing – Original Draft Preparation
;
Catelli E.
Writing – Review & Editing
;
Lupini C.
Membro del Collaboration Group
;
2017

Abstract

IBV genotype QX causes suficient disease in Europe for several commercial companies to have started developing live attenuated vaccines. Here, one of those vaccines (L1148) was fully consensus sequenced alongside its progenitor ield strain (1148-A) to determine vaccines markers, thereby enabling detection on farms. Twenty eight single nucleotide substitutions were associated with the 1148-A attenuation, of which any combination can identify vaccine L1148 in the ield. Sixteen substitutions resulted in amino acid coding changes of which half were in spike. One change in the 1b gene altered the normally highly conserved inal 5 nucleotides of the transcription regulatory sequence of the S gene, common to all IBV QX genes. No mutations can currently be associated with the attenuation process. Field vaccination strategies would greatly beneit by such comparative sequence data being mandatorily submitted to regulators prior to vaccine release following a successful registration process
2017
Atti della Società Italiana di Patologia Aviare 2017 - LVI Convengo Annuale, II Simposio Scientifico
121
129
Listorti V., L.A. (2017). IDENTIFICAZIONE DI MARKER MOLECOLARI PER LA DIFFERENZIAZIONE DI UN VACCINO IBV GENOTIPO QX. Parma : La Ducale Srl.
Listorti V., Laconi A., Catelli E., Cecchinato M., Lupini C., Naylor C.J.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/623991
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact